¼¼°èÀÇ D-¾Æ¹Ì³ë»ê ½ÃÀå
D-Amino Acids
»óǰÄÚµå : 1662232
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 268 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,056,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,169,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è D-¾Æ¹Ì³ë»ê ½ÃÀåÀº 2030³â±îÁö 3¾ï 180¸¸ ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 2¾ï 1,700¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â D-¾Æ¹Ì³ë»ê ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 5.6%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 3¾ï 180¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÀǾàǰ ÃÖÁ¾ »ç¿ëÀº CAGR 5.8%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 2¾ï 1,760¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. »ê¾÷¿ë ÃÖÁ¾ »ç¿ë ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 4.9%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 5,650¸¸ ´Þ·¯, Áß±¹Àº CAGR 8.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ D-¾Æ¹Ì³ë»ê ½ÃÀåÀº 2024³â¿¡ 5,650¸¸ ´Þ·¯¿¡ À̸¥ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 6,860¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â°£ CAGRÀº 8.6%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 3.5%¿Í 4.4%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ D-¾Æ¹Ì³ë»ê ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

D-¾Æ¹Ì³ë»êÀº °ú°Å¿¡´Â Àΰ£¿¡°Ô ÇʼöÀûÀÌÁö ¾ÊÀº °ÍÀ¸·Î ¿©°ÜÁ³Áö¸¸, ´Ù¾çÇÑ »ý¹°ÇÐÀû °úÁ¤¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â °ÍÀ¸·Î ¹àÇôÁ³½À´Ï´Ù. D-¾Æ¹Ì³ë»êÀº ÀϹÝÀûÀÎ L-¾Æ¹Ì³ë»ê°ú ´Þ¸® ¼¼Æ÷ ´ë»ç¿¡ °ü¿©Çϰųª ³ú ¹× ±âŸ Á¶Á÷¿¡¼­ ½ÅÈ£Àü´Þ ºÐÀÚ·Î ÀÛ¿ëÇÏ´Â µî µ¶Æ¯ÇÑ ±â´ÉÀ» °¡Áö°í ÀÖÀ¸¸ç, ³ú, Ä¡¾Æ, ¼öÁ¤Ã¼ µî ÀÎü Á¶Á÷°ú Ç÷Àå, ³úô¼ö¾× µî ü¾×¿¡ Á¸ÀçÇϸç, ¶ó¼¼¸¶Á¦ È¿¼Ò¿¡ ÀÇÇÑ ³»Àμº ÇÕ¼º, ½ÄÀÌ ¼·Ãë, Àå³» ¹Ì»ý¹°¿¡ ÀÇÇÑ ÇÕ¼º ¶ó¼¼¸¶Á¦ È¿¼Ò¿¡ ÀÇÇÑ ³»Àμº ÇÕ¼º, ½ÄÀÌ ¼·Ãë, Àå³» ¹Ì»ý¹°¿¡ ÀÇÇÑ ÇÕ¼º¿¡ ±âÀÎÇÕ´Ï´Ù. ±× Á߿伺¿¡ ´ëÇÑ ÀÌÇØ´Â °Å¿ï»ó ºÐÀÚ¸¦ ±¸º°ÇÒ ¼ö ÀÖ´Â °í¼Ó ¾×ü Å©·Î¸¶Åä±×·¡ÇÇ(HPLC)¿Í °°Àº ºÐ¼® ±â¼ú¿¡ ÀÇÇØ ÇöÀúÇÏ°Ô ¹ßÀüÇÏ¿© ´Ù¾çÇÑ Á¶Á÷¿¡¼­ÀÇ ºÐÆ÷¿Í ³óµµ°¡ ¹àÇôÁ³½À´Ï´Ù.

D-¾Æ¹Ì³ë»ê Á¶»ç´Â ÀÇÇÐ, ƯÈ÷ ¾Ï°ú ¾ËÃ÷ÇÏÀ̸Ӻ´°ú °°Àº Áúº´ÀÇ ÀÌÇØ¿Í Ä¡·á¿¡ Å« Àǹ̰¡ ÀÖÀ¸¸ç, D-¾Æ½ºÆÄ¸£Æ®»ê, D-¼¼¸°, D-¾Ë¶ó´Ñ°ú °°Àº ƯÁ¤ D-¾Æ¹Ì³ë»êÀÇ ¾Ï¼¼Æ÷ ³» Áõ°¡µÈ ¼öÁØÀº Á¶±â ¹ß°ßÀ» À§ÇÑ ¹ÙÀÌ¿À¸¶Ä¿·Î¼­ÀÇ ÀáÀçÀû ¿ªÇÒ °¡´É¼ºÀ» ½Ã»çÇÕ´Ï´Ù. °¡´É¼ºÀ» ½Ã»çÇϰí ÀÖ½À´Ï´Ù. ÀÌµé ¾Æ¹Ì³ë»êÀº ½Å°æ ½ÅÈ£Àü´Þ¿¡ Áß¿äÇÑ NMDA ¼ö¿ëü¸¦ Á¶ÀýÇϸç, ´Ù¾çÇÑ ¾Ï¿¡¼­ ¹ßÇö·®ÀÌ Áõ°¡ÇÏ¿© Á¾¾çÀÇ ¼ºÀå°ú »ýÁ¸¿¡ °ü¿©ÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¾ËÃ÷ÇÏÀ̸Ӻ´¿¡¼­´Â ƯÁ¤ D-¾Æ¹Ì³ë»êµéÀÌ ¥â-¾Æ¹Ð·ÎÀÌµå ÆéŸÀ̵åÀÇ º¯Çü¿¡ °ü¿©ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ º¯ÇüÀ» ÀÌÇØÇϸé Áúº´ÀÇ ÁøÇàÀ» ÆÄ¾ÇÇϰí Ä¡·á Àü·«À» Á¶Á¤ÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¾Ï¼¼Æ÷¿¡¼­ D-¾Æ¹Ì³ë»ê ¼öÁØÀÇ º¯È­¸¦ °¨ÁöÇÏ´Â ´É·ÂÀº ºñħ½ÀÀûÀÌ°í ½Å¼ÓÇÑ Áø´Ü µµ±¸¸¦ Á¦°øÇÏ°í ¾ÏÀ» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ´Â ÀáÀçÀûÀÎ Áø´Ü Å×½ºÆ®ÀÇ °³¹ß·Î À̾îÁ³½À´Ï´Ù.

D-¾Æ¹Ì³ë»ê ¿¬±¸ ¹× ÀÀ¿ëÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¸î °¡Áö ÁÖ¿ä ¿äÀÎÀº ´ÙÀ½°ú °°½À´Ï´Ù. HPLC ¹× Áú·® ºÐ¼®°ú °°Àº ºÐ¼® ±â¼úÀÇ Çâ»óÀ¸·Î D-¾Æ¹Ì³ë»êÀÇ ½Äº° ¹× Á¤·®ÀÌ ´õ ³ôÀº Á¤È®µµ¿Í ¹Î°¨µµ·Î °¡´ÉÇØÁ® ±× ¿ªÇÒ°ú ±â´É¿¡ ´ëÇÑ ½ÉÃþÀûÀÎ ¿¬±¸°¡ ¿ëÀÌÇØÁ³½À´Ï´Ù. ÇÕ¼º»ý¹°ÇÐ ¹× À¯Àü°øÇÐÀ» Æ÷ÇÔÇÑ »ý¸í°øÇÐ ±â¼úÀÇ ¹ßÀüÀ¸·Î D-¾Æ¹Ì³ë»ê »ý»ê ¹× º¯ÇüÀÌ °¡´ÉÇØÁ® ¿¬±¸ ¹× ÀǾàǰ ÀÀ¿ë¿¡ ´ëÇÑ À¯¿ë¼ºÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, D-¾Æ¹Ì³ë»êÀº »ý¹°ÇÐÀû ½Ã½ºÅÛ¿¡¼­ ¾ÈÁ¤¼º°ú À¯È¿¼º, ¾àµ¿ÇÐÀû Ư¼ºÀÌ °³¼±µÇ¾î ÀǾàǰ °³¹ß, ƯÈ÷ ÆéŸÀÌµå ±â¹Ý Ä¡·áÁ¦¿¡ ´ëÇÑ ÀÀ¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Ä¡·áÁ¦ °³¹ß¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, º¸´Ù È¿°úÀûÀÌ°í µ¶¼ºÀÌ ÀûÀº Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ÀǾàǰ ¼³°è ¹× °³¹ß¿¡ D-¾Æ¹Ì³ë»ê Ȱ¿ëÀ» ÃËÁøÇϰí ÀÖÀ¸¸ç, D-¾Æ¹Ì³ë»êÀÇ ÀåÁ¡¿¡ ´ëÇÑ Àνİú ±³À°, Çõ½ÅÀûÀÎ ÀǾàǰ °³¹ß °æ·Î¸¦ Àå·ÁÇÏ´Â ±ÔÁ¦ Á¤Ã¥, »ý¸í°øÇÐ ¹× Á¦¾à ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡·Î ÀÎÇØ D-¾Æ¹Ì³ë»ê Ȱ¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ ¿ëµµ¿¡ ´ëÇÑ Ã¤ÅÃÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ Á¾ÇÕÀûÀ¸·Î D-¾Æ¹Ì³ë»ê(D-amino acids)ÀÇ ´Ù¾çÇÑ °úÇÐÀû ¹× »ó¾÷Àû ºÐ¾ß¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ ¼ö¿ë°ú ÅëÇÕÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

ÃÖÁ¾ ¿ëµµ(Á¦¾à, »ê¾÷, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 31°³ ÁÖ¸ñ ±â¾÷)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global D-Amino Acids Market to Reach US$301.8 Million by 2030

The global market for D-Amino Acids estimated at US$217.0 Million in the year 2024, is expected to reach US$301.8 Million by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Pharmaceutical End-Use, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$217.6 Million by the end of the analysis period. Growth in the Industrial End-Use segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$56.5 Million While China is Forecast to Grow at 8.6% CAGR

The D-Amino Acids market in the U.S. is estimated at US$56.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$68.6 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global D-Amino Acids Market - Key Trends and Drivers Summarized

D-amino acids, once considered non-essential in humans, have been revealed to play crucial roles in various biological processes. Unlike their more prevalent counterparts, L-amino acids, D-amino acids have unique functions, including involvement in cellular metabolism and acting as signaling molecules in the brain and other tissues. Found in human tissues such as the brain, teeth, and eye lens, as well as in bodily fluids like blood plasma and cerebrospinal fluid, D-amino acids originate from endogenous synthesis through racemase enzymes, dietary intake, and microbial synthesis in the gut. The understanding of their importance has been significantly advanced by analytical techniques like high-performance liquid chromatography (HPLC), which can differentiate between mirror-image molecules, revealing their distribution and concentration in various tissues.

The research into D-amino acids has profound implications for medical science, particularly in understanding and treating diseases such as cancer and Alzheimer's. Elevated levels of specific D-amino acids, like D-aspartic acid, D-serine, and D-alanine, in cancer cells suggest their potential role as biomarkers for early detection. These amino acids modulate NMDA receptors crucial for neural signaling and are upregulated in various cancers, indicating their involvement in tumor growth and survival. In Alzheimer's disease, certain D-amino acids are involved in the modification of beta-amyloid peptides, which accumulate in the brain and are a hallmark of the disease. Understanding these modifications helps in pinpointing disease progression and tailoring therapeutic strategies. The ability to detect changes in D-amino acid levels in cancer cells has led to the development of potential diagnostic tests for early cancer detection, offering a non-invasive, rapid diagnostic tool.

Several key factors are driving the growth of research and applications in D-amino acids. Enhanced analytical techniques like HPLC and mass spectrometry have made it possible to identify and quantify D-amino acids with greater accuracy and sensitivity, facilitating detailed studies of their roles and functions. Advances in biotechnology, including synthetic biology and genetic engineering, enable the production and modification of D-amino acids, enhancing their utility in research and pharmaceutical applications. The incorporation of D-amino acids in drug development, particularly in peptide-based therapeutics, has increased due to their stability and efficacy in biological systems, improving pharmacokinetic properties of drugs. Additionally, there is a rising demand for more effective and less toxic therapeutic options, driving the incorporation of D-amino acids in drug design and development. Increased awareness and education about the benefits of D-amino acids are expanding their adoption in various applications, supported by regulatory policies that encourage innovative drug development pathways and increased investment in biotechnology and pharmaceutical research. These factors collectively promote the broader acceptance and integration of D-amino acids into various scientific and commercial fields.

SCOPE OF STUDY:

The report analyzes the D-Amino Acids market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Pharmaceutical, Industrial, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 31 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â